Diagnostic Imaging Devices - Australia & Oceania

  • Australia & Oceania
  • The Diagnostic Imaging Devices market market in Australia & Oceania is expected to achieve a projected revenue of US$0.82bn in 2024.
  • Looking ahead, the market is anticipated to exhibit a steady annual growth rate (CAGR 2024-2029) of 5.07%, leading to a market volume of US$1.05bn by 2029.
  • In terms of global comparison, the United States is projected to generate the highest revenue, reaching US$11,930.00m in 2024.
  • Australia's demand for advanced diagnostic imaging devices in the medical technology market is rapidly increasing due to the country's aging population and growing healthcare infrastructure.

Key regions: Germany, Japan, Netherlands, Spain, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diagnostic Imaging Devices market in Australia & Oceania is experiencing steady growth due to increasing customer preferences for advanced medical imaging technologies.

Customer preferences:
Customers in Australia & Oceania are increasingly demanding diagnostic imaging devices that offer high-quality imaging, faster scanning times, and improved patient comfort. They prefer devices that provide accurate and detailed images, allowing healthcare professionals to make more accurate diagnoses. Additionally, there is a growing preference for portable and compact imaging devices that can be easily transported to remote areas or smaller healthcare facilities.

Trends in the market:
One of the key trends in the Diagnostic Imaging Devices market in Australia & Oceania is the adoption of digital imaging technologies. Digital imaging devices offer several advantages over traditional film-based devices, including faster image acquisition, better image quality, and easier storage and retrieval of images. This trend is driven by the increasing availability of digital imaging technologies and the growing need for efficient and cost-effective healthcare solutions. Another trend in the market is the integration of artificial intelligence (AI) and machine learning (ML) technologies in diagnostic imaging devices. AI and ML algorithms can analyze medical images and provide valuable insights to healthcare professionals, aiding in the diagnosis and treatment of various medical conditions. This trend is driven by the potential of AI and ML to improve the accuracy and efficiency of medical imaging, leading to better patient outcomes.

Local special circumstances:
Australia & Oceania is a geographically diverse region with many remote and rural areas. This presents unique challenges in terms of healthcare access and delivery. Diagnostic imaging devices that are portable and can be easily transported to these areas are in high demand. Additionally, the region has a high prevalence of certain medical conditions, such as skin cancer, which require specialized imaging techniques. This creates a need for imaging devices that are specifically designed to address these local healthcare challenges.

Underlying macroeconomic factors:
The growing demand for diagnostic imaging devices in Australia & Oceania is also influenced by underlying macroeconomic factors. The region has a growing population, which increases the demand for healthcare services, including diagnostic imaging. Additionally, advancements in technology and healthcare infrastructure have made diagnostic imaging more accessible and affordable, leading to increased adoption. Furthermore, government initiatives and investments in healthcare infrastructure are driving the growth of the diagnostic imaging market in the region. In conclusion, the Diagnostic Imaging Devices market in Australia & Oceania is experiencing growth due to increasing customer preferences for advanced imaging technologies, such as digital imaging and AI/ML integration. The region's unique healthcare challenges, including remote areas and specific medical conditions, contribute to the demand for portable and specialized imaging devices. The growing population and government investments in healthcare infrastructure are also driving the market growth.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)